HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nanping Lin Selected Research

Nanping Lin Research Topics

Disease

3Neoplasms (Cancer)
01/2021 - 12/2018
3Cholangiocarcinoma
01/2020 - 03/2019
2Hepatocellular Carcinoma (Hepatoma)
01/2021 - 01/2020
2Lymphatic Metastasis
01/2020 - 03/2019
2Klatskin Tumor
01/2020 - 07/2019
2Neoplasm Metastasis (Metastasis)
07/2019 - 03/2019
1Hepatitis
01/2021
1Fibrosis (Cirrhosis)
01/2021
1Hemorrhage
09/2020
1Margins of Excision
01/2020
1Liver Cirrhosis (Hepatic Cirrhosis)
01/2020
1Pancreatic Neoplasms (Pancreatic Cancer)
07/2019
1Liver Neoplasms (Liver Cancer)
12/2018

Drug/Important Bio-Agent (IBA)

2perfluoro- 2,2,2',2'- tetramethyl- 4,4'- bis(1,3- dioxolane)IBA
07/2019 - 03/2019
1Capsules (Microcapsules)IBA
01/2021
16-propylchromone-2-carboxylic acid (PCCA)IBA
01/2020
1AlbuminsIBA
01/2020
1C-Reactive ProteinIBA
01/2020
1Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2020
1ORALIT (ORS)IBA
07/2019
1Biomarkers (Surrogate Marker)IBA
12/2018
1mesoglycanIBA
12/2018
1MetallothioneinIBA
12/2018

Therapy/Procedure

3Hepatectomy
01/2021 - 01/2020
1Chemoradiotherapy
01/2020
1Drug Therapy (Chemotherapy)
01/2020
1Radiotherapy
01/2020
1Therapeutics
01/2020
1Blood Transfusion (Blood Transfusions)
03/2019